Why the study?
Do risk factor profiles and medication use differ between men and women with atrial fibrillation in Japan?
Do risk factor profiles and medication use differ between men and women with atrial fibrillation in Japan?
In Japanese patients with atrial fibrillation, women have a higher thromboembolic risk profile (CHADS2 score) than men, primarily driven by older age and higher prevalence of heart failure, yet warfarin usage remains similar.
No takes yet. Share an insight, caveat, or question.
Women with AF may need heightened risk vigilance despite similar warfarin use; leaves open whether sex-specific thresholds should guide anticoagulation in Japan.
Inoue et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: